Following up on the recent letter from Dr. John Lazo and Dr. Rick Neubig, you can now donate online to the John J. Abel Award, the Julius Axelrod Award, the Goodman and Gilman Award in Receptor Pharmacology, and the Torald Sollmann Award, and by going to the respective awards pages, you can watch the endowments grow. Click on the above link to donate.

Take a look at what's happening at ASPET. View the current edition of our eNewsletter.

At the ASPET Annual Meeting at EB 2013 held in Boston, MA from April 20 – 24, William B. Campbell, Ph.D., Professor and Chairman of Pharmacology and Toxicology at Medical College of Wisconsin, was presented with the 2013 PhRMA Foundation Award in Excellence...

Drexel University recently appointed James E. Barrett, Ph.D., founding director of the Clinical and Translational Research Institute. The Clinical and Translational Research Institute is a new University-wide initiative housed in the Drexel University College of Medicine...

FASEB is pleased to announce its release of the latest edition of the 'Breakthroughs in Bioscience' series: “Conquering Cancer with Drugs from Nature’s Medicine Cabinet.”...

The House released its 302(b) allocations for FY 2014. The "302b" refers to the total number of dollars that each appropriations subcommittee can spend on programs under that subcommittee's jurisdiction. Subcommittees cannot spend above the 302(b) spending limit...

The NIH National Center for Advancing Translational Sciences (NCATS) is requesting comments on ways to avoid duplication, redundancy, and competition with industry activities...

The Chairman of the House Science, Space and Technology Committee, Lamar Smith (R-TX) introduced the “High Quality Research Act,” that mandates public certification by the Director of the National Science Foundation that every NSF grant meets certain requirements...

NIH released complete fiscal policy information on the agency’s FY 2013 operating plans. As a result of the sequestration, the NIH budget for FY 2013 falls to $29.15 billion, a $1.6 billion or 5.5% reduction from FY 2012. Research Project Grants decline by 6.1%, including reductions of 4.9% for noncompeting awards and 8.6% for competing awards...

Click on the above link to be directed to the Alliance for a Stronger FDA's written Congressional testimony.